PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Recently Added NEW Latest cases added to the library
AUTH/3282/11/19
Gilead Sciences Europe
Social Media & Digital · 2019
▶ Video 🎧 Podcast
AUTH/2991/11/17
Pfizer
Samples & Gifts · 2015
▶ Video 🎧 Podcast
AUTH/2082/1/08
Recordati Pharmaceuticals
Promotional Material · 2019
▶ Video 🎧 Podcast
AUTH/2079/1/08
Gamble Pharmaceuticals UK
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2102/2/08
Meda Pharmaceuticals
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2149/7/08
Syner-Med
Promotional Material · 2008
▶ Video 🎧 Podcast
AUTH/2428/8/11
AstraZeneca
Scientific Information · 2008
▶ Video 🎧 Podcast
AUTH/1899/10/06
AstraZeneca
Samples & Gifts · 2019
▶ Video 🎧 Podcast
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 169 results · CNS & Neurology  · Clear
🔒 Subscribers only
AUTH/3917/6/24
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Jazz Pharmaceuticals
An anonymous, contactable health professional complained about two Jazz-funded online presentations for UK health professionals about Epidyolex (cannabidiol).Video 1 (“Understanding the Pharmacol…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3885/3/24
HCP Hospitality & Meetings Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia Pharmaceuticals
EVER Pharma complained that Britannia promoted APO-go (apomorphine hydrochloride) outside its marketing authorisation via a company-funded nurse service and at a sponsored meeting.The SmPC (section…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3894/4/24
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Merck Serono
An anonymous, non-contactable complainant challenged a UK health professional’s LinkedIn post that linked to slides from a Barcelona (Spain) meeting (27 April 2024) organised and funded by Merck …
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3916/5/24
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Angelini
A former employee complained about Angelini’s promotional activities for Ontozry (cenobamate) across three meeting settings in 2023: a UK meeting (Southern Epilepsy Forum), a UK “Cenobamate Roa…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3768/5/23
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sandoz
A neurologist complained about Sandoz advance budgetary notification (ABN) materials (a full slide deck and a 2-page summary) for a natalizumab biosimilar for multiple sclerosis, before UK marketin…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3726/1/23
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
UCB
A LinkedIn post was shared by a UCB employee based in Germany stating: “Hope for patients with Lennox-Gastaut Syndrome!”.The post linked to a third-party website article titled: “Epilepsia Pu…
Clauses: 27.1
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3722/1/23
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka
An anonymous, contactable complainant (representing a group of employees/former employees) complained about annual “Awareness, Trial, and Usage (ATU)” tracking market research commissioned by O…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3723/1/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
An anonymous, contactable complainant alleged that annual, repeated market research (2018–2021) commissioned by Lundbeck A/S (Global) and Otsuka Europe Ltd had a promotional purpose.The research …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3747/2/23
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka UK
An anonymous complainant challenged a LinkedIn post made by Otsuka US about ulotaront (SEP-363859/SEP-363856) for adjunctive treatment of major depressive disorder (MDD), calling it promotion of an…
Clauses: 9.1,9.2
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3749/3/23
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
AGB-Pharma
A complainant reported a website that appeared to advertise a UK prescription-only medicine (Adaflex) without restriction and freely accessible to the public.The Adaflex branded webpage included a …
Clauses: 9.1,4.1
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3827/9/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Roche
An anonymous, non-contactable complainant (self-described health professional) complained about a Roche promotional webpage about Ocrevus infusion schedules. The complainant alleged the graphic was…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3728/1/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Bristol Myers Squibb
A complaint was made alleging promotion of Zeposia (ozanimod hydrochloride) by Bristol Myers Squibb.Complaint received: 11 January 2023.Case completed: 20 February 2024.
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3868/12/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Rosemont Pharmaceuticals
An anonymous, non-contactable complainant (described as a health professional) alleged a patient saw Rosemont “advertising on LinkedIn”, then accessed “a large range of promotional material�…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3856/11/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
PMCPA AUTH/3856/11/23
An anonymous, contactable complainant challenged two Idorsia banner advertisements on a UK news website for general practitioners.Both ads related to Quviviq (daridorexant) for insomnia and used th…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3656/6/22
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Teva
A health professional complained about a P3 Pharmacy article (an interview/profile involving a Teva senior leader) that mentioned Ajovy and Copaxone.Teva argued the piece was a third-party, biograp…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3606/1/22
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Accord
A health professional complained about Accord UK Ltd’s promotion of the buprenorphine implant Sixmo 74.2mg after participating in market research for the campaign.The complainant alleged the camp…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3609/2/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia Pharmaceuticals
Britannia Pharmaceuticals Ltd made a voluntary admission about incorrect prescribing information (PI) availability on the APO-go (apomorphine hydrochloride) promotional website, which was developed…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3602/1/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Teva
A UK health professional complained about the Ajovy (fremanezumab) website (www.ajovy.co.uk), focusing on the initial landing-page pop-up.The pop-up asked users to confirm whether they were a healt…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3651/5/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Roche
An anonymous, contactable health professional complained about the Ocrevus (ocrelizumab) landing page on the Roche Resources website.The landing page included the claim: “Ocrevus was generally we…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3658/6/22
HCP Hospitality & Meetings Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
An anonymous, contactable complainant (a health professional) complained about an email distributed by a multiple sclerosis independent education provider inviting recipients to a webinar that incl…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3628/4/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
An anonymous, contactable complainant (a health professional) complained about six press releases in the news section of Novartis’ UK corporate website. The complainant alleged Novartis was proac…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3643/5/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis breached Code over Kesimpta SMC “approval” stamp and UK digital ad (missing ‘adult’ + NI pr
An anonymous, contactable health professional complained about Kesimpta (ofatumumab) promotion on: (1) a Novartis product webpage (ref 199247, April 2021) and (2) a digital banner advertisement (re…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3659/6/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Teva breached Code over Ajovy HCP registration website
An anonymous, contactable complainant (self-described health professional) complained about a Teva UK registration website for HCPs to access recorded webinar highlights about Ajovy (fremanezumab):…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3662/6/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
An anonymous complainant challenged Novartis’ certification of a sponsored multiple sclerosis (MS) disease-awareness article published on MailOnline, including the share buttons and the content g…
Clauses: NONE
2022 🔒 Subscribe
1 2 3 4 Next → Page 1 of 8 — 169 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews